HSBC Holdings’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-8,483
| Closed | -$126K | – | 2683 |
|
2024
Q1 | $126K | Buy |
8,483
+6,373
| +302% | +$94.3K | ﹤0.01% | 2390 |
|
2023
Q4 | $31.2K | Hold |
2,110
| – | – | ﹤0.01% | 2193 |
|
2023
Q3 | $22.7K | Buy |
2,110
+13
| +0.6% | +$140 | ﹤0.01% | 2138 |
|
2023
Q2 | $27.3K | Hold |
2,097
| – | – | ﹤0.01% | 2065 |
|
2023
Q1 | $27.9K | Buy |
+2,097
| New | +$27.9K | ﹤0.01% | 2154 |
|
2021
Q2 | – | Sell |
-7,882
| Closed | -$269K | – | 2564 |
|
2021
Q1 | $269K | Sell |
7,882
-11,363
| -59% | -$388K | ﹤0.01% | 2014 |
|
2020
Q4 | $679K | Hold |
19,245
| – | – | ﹤0.01% | 1585 |
|
2020
Q3 | $465K | Sell |
19,245
-2,413
| -11% | -$58.3K | ﹤0.01% | 1599 |
|
2020
Q2 | $396K | Buy |
21,658
+6,057
| +39% | +$111K | ﹤0.01% | 1632 |
|
2020
Q1 | $243K | Buy |
15,601
+62
| +0.4% | +$966 | ﹤0.01% | 1773 |
|
2019
Q4 | $336K | Sell |
15,539
-1,731
| -10% | -$37.4K | ﹤0.01% | 1943 |
|
2019
Q3 | $323K | Buy |
17,270
+16,264
| +1,617% | +$304K | ﹤0.01% | 2003 |
|
2019
Q2 | $26K | Sell |
1,006
-104
| -9% | -$2.69K | ﹤0.01% | 2083 |
|
2019
Q1 | $29K | Buy |
+1,110
| New | +$29K | ﹤0.01% | 2120 |
|
2017
Q1 | – | Sell |
-1,723
| Closed | -$41K | – | 1999 |
|
2016
Q4 | $41K | Buy |
+1,723
| New | +$41K | ﹤0.01% | 2223 |
|